Key Insights

Highlights

Success Rate

69% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

12.1%

4 terminated out of 33 trials

Success Rate

69.2%

-17.3% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

22%

2 of 9 completed with results

Key Signals

2 with results69% success

Data Visualizations

Phase Distribution

26Total
Not Applicable (12)
P 1 (12)
P 2 (2)

Trial Status

Completed9
Recruiting8
Terminated4
Withdrawn3
Active Not Recruiting3
Not Yet Recruiting3

Trial Success Rate

69.2%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (33)

Showing 20 of 20 trials
NCT07558395Not ApplicableNot Yet Recruiting

Effectiveness of a Visual Telerehabilitation Program on Visual Perception in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour

NCT05887882Phase 1SuspendedPrimary

Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors

NCT03911388Phase 1Recruiting

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

NCT05521984Phase 1RecruitingPrimary

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

NCT03478462Phase 1Active Not Recruiting

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

NCT05740839Not ApplicableRecruitingPrimary

High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study

NCT07087002Phase 1Recruiting

GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

NCT06907485Phase 2Not Yet RecruitingPrimary

A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients

NCT07321353Not ApplicableRecruitingPrimary

Survivors Journey+

NCT03208387Active Not Recruiting

Understanding the Late Effects of Surviving a Pediatric Brain Tumor

NCT03330197Phase 1TerminatedPrimary

A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG

NCT07094360Not ApplicableCompletedPrimary

Effect of Hydrotherapy on Children With Brain Tumor

NCT04239092Phase 1Terminated

9-ING-41 in Pediatric Patients With Refractory Malignancies.

NCT05367076Not ApplicableCompletedPrimary

Fitness to Aid the Brain and Cognitive Skills

NCT03739372Not ApplicableActive Not Recruiting

Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma

NCT06981156RecruitingPrimary

Evaluation of the Neurologic Assessment in Pediatric Neuro-Oncology (pNANO)

NCT06943742RecruitingPrimary

Non-Helium Magnetoencephalography in Pediatric Brain Tumors

NCT06770335Not ApplicableNot Yet Recruiting

The FLaME Cognitive Rehabilitation Study for Childhood Brain Tumour

NCT05528939Not ApplicableRecruiting

Feasibility/Acceptability of Attentional-Control Training in Survivors

NCT03434262Phase 1Completed

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors

Scroll to load more

Research Network

Activity Timeline